-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The net result for the period of deducting operating expenses from operating revenues.
-
Summary
-
Boundless Bio, Inc. quarterly/annual Operating Income (Loss) history and change rate from Q1 2023 to Q3 2025.
- Boundless Bio, Inc. Operating Income (Loss) for the quarter ending September 30, 2025 was -$15.1M, a 19.1% increase year-over-year.
- Boundless Bio, Inc. Operating Income (Loss) for the twelve months ending September 30, 2025 was -$67.8M, a 1.39% increase year-over-year.
- Boundless Bio, Inc. annual Operating Income (Loss) for 2024 was -$73.3M, a 33.7% decline from 2023.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Change (%)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Change (%)